p11187
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2013 (NCT01874366)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Free fatty acid receptor 1INHIBITOR
FFAR1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- p11187
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01874366 | Phase 1 | Jun 1, 2013 | IQVIA, MRA Clinical Research, Piramal |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| IQVIA | For profit | 1 | 0 | 1 | 2013 |
| MRA Clinical Research | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Piramal | For profit | 1 | 1 | 1 | 2013 |
3 organizations
Page 1 / 1